Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects.
Bakker, Guido J
Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects. [electronic resource] - Physiological reports 08 2019 - e14199 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
2051-817X
10.14814/phy2.14199 doi
Adult
Anti-Bacterial Agents--pharmacology
Dietary Fats--adverse effects
Gastrointestinal Microbiome--drug effects
Humans
Inflammation--metabolism
Lipopolysaccharides--blood
Male
Metabolic Syndrome--metabolism
Middle Aged
Monocytes--drug effects
Obesity--metabolism
Postprandial Period--drug effects
Vancomycin--pharmacology
Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects. [electronic resource] - Physiological reports 08 2019 - e14199 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
2051-817X
10.14814/phy2.14199 doi
Adult
Anti-Bacterial Agents--pharmacology
Dietary Fats--adverse effects
Gastrointestinal Microbiome--drug effects
Humans
Inflammation--metabolism
Lipopolysaccharides--blood
Male
Metabolic Syndrome--metabolism
Middle Aged
Monocytes--drug effects
Obesity--metabolism
Postprandial Period--drug effects
Vancomycin--pharmacology